Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 42 out of 100. Cognitive tests and assessment

Topic: Amyloid, tau and blood-test diagnosis

Plain-language summary

AcTau174 levels were elevated in all dementia groups compared to controls, with a stepwise increase from controls to MCI-AD (2.2-fold) to AD dementia (3.5-fold, Figure 1). The strongest increase compared to controls was observed in the FTD group, wherein AcTau174 distinguished FTD from controls with a high area under the curve (AUC) accuracy of 0.95 (95%CI:0.92;0.99), significantly outperforming CSF pTau181 (AUC=0.65, 95%CI:0.55;0.75) and CSF Tau (AUC=0.83, 95%CI:0.75;0.91). AcTau174 showed high accuracy for differentiating AD (AUC=0.98, 95%CI:0.96;0.99) and MCI-AD (AUC=0.89, 95%CI:0.84;0.93) from controls (Figure 2). In FTD, AcTau174 correlated with MMSE (ρ=-0.29, p =0.039), and in AD with the frontal assessment battery score (ρ=-0.35, p =0.0001). In FTD, higher baseline CSF AcTau174 was associated with a faster rate of decline in MMSE over time (β=-1.64, 95%CI:-2.61;-0.87, p =0.0014, Figure 3), which was not observed for CSF pTau181 or Tau. Higher baseline CSF AcTau174 also predicted faster MMSE decline within AD (β=-1.66, 95%CI:-2.44;-0.90, p <0.0001) and MCI-AD (β=-0.67, 95%CI:-1.09;-0.27, p =0.002, Figure 3). CSF AcTau174 shows great diagnostic value across neurodegenerative dementias and is strongly associated with clinical progression. In FTD, where trials are limited by clinical heterogeneity and lack of fluid biomarkers, AcTau174 may aid in identifying patients at risk of rapid decline, supporting trial enrichment and more targeted intervention strategies. Its predictive capacity for MMSE decline highlights its potential as a progression biomarker, both for patient monitoring and therapeutic development.

What this study adds

Evidence grade: Moderate

This study found that a form of acetylated tau in spinal fluid was elevated in several dementias and was linked to faster cognitive decline. Reported effect size: AUC=0.65; AUC=0.83; AUC=0.98.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Honey, M. I. J., Hok-A-Hin, Y. S., Thijssen, E. H., van der Weijden, B., Stoops, E., de Boer, S. C., et al. (2025). CSF Acetylated Tau‐174 as a novel diagnostic and prognostic biomarker in Frontotemporal Dementia and Alzheimer’s Disease. Alzheimer s & Dementia. https://doi.org/10.1002/alz70861_108639

Vancouver

Honey MIJ, Hok-A-Hin YS, Thijssen EH, van der Weijden B, Stoops E, de Boer SC, et al. CSF Acetylated Tau‐174 as a novel diagnostic and prognostic biomarker in Frontotemporal Dementia and Alzheimer’s Disease. Alzheimer s & Dementia. 2025. doi:10.1002/alz70861_108639. PMID: 41434517.

BibTeX

@article{honey2025-41434517,
  author  = {Honey, Madison I. J. and Hok-A-Hin, Yanaika Sylvana and Thijssen, Elisabeth H. and van der Weijden, Babette and Stoops, Erik and de Boer, Sterre C.M. and Duits, Flora Hillegonde and van der Ende, Emma Louise and others},
  title   = {{CSF Acetylated Tau‐174 as a novel diagnostic and prognostic biomarker in Frontotemporal Dementia and Alzheimer’s Disease}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70861_108639},
  pmid    = {41434517},
  url     = {https://doi.org/10.1002/alz70861_108639}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

This study found that a form of acetylated tau in spinal fluid was elevated in several dementias and was linked to faster cognitive decline. It may help diagnose and predict progression, but it is a biomarker study and does not test any treatment.

Study details

How this study scored 42/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 3 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 4 of 4; Institution's track record 1 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 42 of 100.42 of 100 points earned58 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.3 citations a year over 3 year(s) since 2025
Impact for its field and year 1 / 6 Cited 0.5× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 4 / 4 Last-listed author Charlotte Elisabeth Teunissen: h-index 116 (OpenAlex, whole career)
Institution's track record 1 / 3 Weill Cornell Medicine: institution h-index 1,163 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 6 institution(s) in 3 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41434517)
Free to read 2 / 2 Free to read
Total 42 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Related studies in Cognitive tests and assessment from nearby years

Also tagged “phosphorylated”

732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Cognitive tests and assessment

See all studies in Cognitive tests and assessment →